Alon Y. Hershko

Alon Y. Hershko

Auto-generated profile, based on publicly available information

Alon Y. Hershko

Allergy and Clinical Immunology Unit, Department of Medicine, Hadassah Medical Center, Faculty of Medicine, Hebrew University of Jerusalem, Israel

Research Focus & Metrics

Academic Career Length

19Years (2008-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
13 January 2023 in Journal of Controlled Release
Verified
Journal Article
Closed access
YBYaelle Bavli
Yaelle Bavli
BCBing-Mae Chen
Bing-Mae Chen
GGGuy Gross
Guy Gross
AHAlon Hershko
Alon Hershko
KTKeren Turjeman
Keren Turjeman
YBYechezkel Barenholz
Yechezkel Barenholz

31 July 2018 in Annals of Medicine
Verified
Journal Article
Closed access
OWOri Wand
Ori Wand
Oshrat E. Tayer-ShifmanOshrat E. Tayer-Shifman
Oshrat E. Tayer-Shifman
SKShafik Khoury
Shafik Khoury
AHAlon Y. Hershko
Alon Y. Hershko
Introduction: There are insufficient data on the aetiologic factors underlying splenic infarction (SI). Therefore, there is no consensus regarding the appropriate diagnostic approach. Methods: We conducted a retrospective analysis of all patients admitted with SI from January 2004 to December 2014. Medical records were screened for the clinical presentation, underlying causes, associated medical conditions and methods of patient evaluation. Results: We found 89 subjects with 90 episodes of SI. Presentation of SI was characterized by abdominal, flank and chest pain (82.2%, 18.9%, 7.8%, respectively); leukocytosis (in 67% of tested subjects); elevated LDH (72%), CRP (97.5%) and D-Dimer (100%). The main underlying mechanisms were cardioembolic (54.4%), vascular (20%), haematologic disorders (15.6%) and multiple causes (21.1%). Atrial fibrillation and atherosclerosis were common in older patients (age > 70 years) while antiphospholipid syndrome occurred exclusively in younger individuals. SI was the presentation of previously unknown medical conditions in 38% of patients. Abdominal CT, ECG, echocardiography and blood cultures demonstrated the highest diagnostic yield. Conclusions: Contributing factors are identified in the majority of SI patients. We recommend CT, ECG, echocardiography and blood cultures in all cases. Atrial fibrillation should be sought in older patients, while APLS and haematologic disorders should be suspected in younger ones.

1 October 2008 in Seminars in Arthritis and Rheumatism
Verified
Journal Article
Closed access
AHAlon Y. Hershko
Alon Y. Hershko
YBYackov Berkun
Yackov Berkun
DMDror Mevorach
Dror Mevorach
ARAlan Rubinow
Alan Rubinow
YNYaakov Naparstek
Yaakov Naparstek

26 September 2017 in Clinical & Experimental Allergy
Verified
Journal Article
Closed access
PDF file
PSP. Salamon
P. Salamon
ISI. Shefler
I. Shefler
IMI. Moshkovits
I. Moshkovits
AMA. Munitz
A. Munitz
DKD. Horwitz Klotzman
D. Horwitz Klotzman
AHA. Y. Hershko
A. Y. Hershko

1 November 2011 in Current Pharmaceutical Design
Verified
Journal Article
Closed access
PDF file
ISIrit Shefler
Irit Shefler
PSPazit Salamon
Pazit Salamon
AHAlon Y. Hershko
Alon Y. Hershko
YMYoseph A. Mekori
Yoseph A. Mekori
In addition to being major effector cells in the elicitation of allergic responses, mast cells have been found to play a significant role in the establishment of innate and adaptive immune responses. This occurs, in part, by regulating the phenotype and function of immune cells such as T cells, B cells and dendritic cells, and by acting as antigen presenting cells. Indeed, mast cells have been found to be activated in various T cell-mediated inflammatory processes and to reside in close physical proximity to T cells. Such observations have led investigators to propose a functional relationship between these two cell populations. Mast cells can interact with other cells including T cells in several ways such as cell-cell interaction via membrane associated receptors, release of cytokines and chemokines or by heterotypic adhesion to activated T cells. In this review, we focus on a novel communication pathway between mast cells and other inflammatory cells that occurs by the release of or response to membrane vesicles. Membrane vesicles are circular fragments, released from the endosomal compartment as exosomes or shed from the cell plasma membrane as microparticles. Because their membrane orientation is the same as that of the donor cell, they can be considered to be miniature versions of a cell. Growing evidence indicates that microparticles play a pivotal role in cell to cell communication. The functional consequences of such membrane transfers include the induction, amplification and/or modulation of immune responses, as well as the acquisition of new functional properties by recipient cells.

1 April 2021 in Allergology International
Verified
Journal Article
Open access
OSOded Shamriz
Oded Shamriz
AHAlon Y. Hershko
Alon Y. Hershko
ATAviv Talmon
Aviv Talmon
YRYaarit Ribak
Yaarit Ribak
AEAnat Scheiman Elazary
Anat Scheiman Elazary
YTYuval Tal
Yuval Tal